Why give low‑dose hydrocortisone to an adult with septic shock who remains hypotensive despite adequate fluid resuscitation and requires high‑dose vasopressors?

Why Steroids Are Given in Septic Shock

Core Mechanism and Indication

Hydrocortisone 200 mg/day IV is given in septic shock to reverse vasopressor-refractory hypotension by correcting relative adrenal insufficiency and restoring vascular responsiveness to catecholamines. 1, 2

The rationale is straightforward:

• Septic shock impairs the hypothalamic-pituitary-adrenal axis, creating a state of critical illness-related corticosteroid insufficiency where endogenous cortisol cannot meet the markedly increased metabolic demands 2
• This relative adrenal deficiency (present in ~60% of patients five days after recovery) depletes posterior-pituitary vasopressin stores and down-regulates adrenergic receptors 2
• Hydrocortisone provides catecholamine-independent vasoconstriction and restores receptor sensitivity, allowing vasopressors to work effectively 2

Specific Clinical Threshold for Initiation

Start hydrocortisone only when MAP remains <65 mmHg despite ≥30 mL/kg crystalloid resuscitation AND norepinephrine >0.1–0.2 µg/kg/min for more than 60 minutes. 2, 3

This narrow indication reflects:

• No benefit in less severe shock: The CORTICUS trial showed no mortality benefit when hydrocortisone was given to all septic shock patients regardless of vasopressor responsiveness 4
• Benefit confined to refractory shock: The French Annane trial demonstrated mortality reduction (53% vs 63%, HR 0.67, p=0.02) only in patients with vasopressor-unresponsive shock 2
• Baseline mortality predicts benefit: The survival advantage appears only in higher-risk populations (61% mortality in the French trial vs 31% in CORTICUS) 2

Evidence-Based Benefits

High-Certainty Physiologic Effects

• Accelerates shock reversal: Hazard ratio ≈1.9 for earlier vasopressor discontinuation 2
• Reduces total vasopressor requirements: Consistently observed across major trials 1, 2
• Median time to vasopressor cessation: 2 days with hydrocortisone vs 7 days with placebo (p=0.005) 5

Mortality Evidence (Low-Quality)

• No overall mortality benefit in unselected septic shock populations 4
• Possible mortality reduction in the most severely ill subgroup with refractory shock 2
• The quality of evidence for mortality is considered low due to inconsistency and imprecision 1

Dosing Protocol

Standard regimen: 200 mg/day as continuous IV infusion (preferred) or 50 mg IV every 6 hours. 1, 2, 3

• Duration: Maintain full dose for at least 3 days before considering reduction 1, 2, 3
• Tapering: Begin only after vasopressors discontinued; taper gradually over 6–14 days 1, 2, 3
• Maximum dose ceiling: Do not exceed 400 mg/day—higher doses provide no additional benefit and increase harm 1, 2

Critical Contraindications and Pitfalls

Do NOT give hydrocortisone if:

• Hemodynamic stability achieved with fluids and low-dose vasopressor 2
• Sepsis without shock (no vasopressor requirement) 1, 3
• Patient is responding adequately to initial resuscitation 2

Avoid these common errors:

• ACTH stimulation testing: Not recommended—does not predict benefit and delays treatment 2, 3
• Fludrocortisone addition: No improvement in shock-free days or mortality; strong recommendation against combination 2
• Abrupt discontinuation: Causes rebound inflammation and hemodynamic deterioration 1, 2
• Etomidate for intubation: Suppresses adrenal function and may worsen outcomes 3

Monitoring Requirements

• Hyperglycemia: Most common adverse event; check glucose regularly 1
• Hypernatremia: Monitor serum sodium, especially after 48–72 hours 2, 3
• Superinfection risk: Low-dose regimens (200 mg/day) show no significant increase in infection rates 1, 2

Strength of Recommendation

The Surviving Sepsis Campaign and Society of Critical Care Medicine issue a conditional recommendation (Grade 2C) for hydrocortisone in vasopressor-refractory septic shock, reflecting low-quality evidence for mortality benefit but high-certainty evidence for faster shock reversal. 1, 2